APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microphysiological System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microphysiological System Market Outlook and Growth Opportunities 2026

28 December 2025217 pages

Choose your research edition.

Industry ResearchMicrophysiological System Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Microphysiological System Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Microphysiological System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microphysiological System Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Microphysiological System Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Microphysiological System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microphysiological System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microphysiological System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microphysiological System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microphysiological System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microphysiological System market include Emulate, Mimetas, TissUse, InSphero, Hesperos, CN Bio, TNO, 28bio and Beijing Daxiang Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microphysiological System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microphysiological System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microphysiological System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microphysiological System market.

Microphysiological System Segment by Company

Emulate

Mimetas

TissUse

InSphero

Hesperos

CN Bio

TNO

28bio

Beijing Daxiang Biotech

Newcells Biotech

Nortis (Quris-Al)

Valo Health (TARA Biosystems)

Altis Biosystems

Draper Laboratory

Netri

Bi/ond

ImmuONE

AlveoliX

Cherry Biotech

Ananda Devices

Obatala Sciences

BiomimX

React4life

Aracari Bio

StemPharm

SynVivo

Microphysiological System Segment by Type

Human Organ and Tissue Models

Disease Models

Non-Human Species Models

Microphysiological System Segment by Application

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

Microphysiological System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microphysiological System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microphysiological System key companies, revenue, market share, and recent developments.

3. To split the Microphysiological System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microphysiological System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microphysiological System significant trends, drivers, influence factors in global and regions.

6. To analyze Microphysiological System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microphysiological System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microphysiological System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microphysiological System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microphysiological System industry.

Chapter 3: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microphysiological System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microphysiological System Industry Trends Table 2. Microphysiological System Industry Drivers Table 3. Microphysiological System Industry Opportunities and Challenges Table 4. Microphysiological System Industry Restraints Table 5. Global Microphysiological System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microphysiological System Revenue Share by Company (2021-2026) Table 7. Global Microphysiological System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microphysiological System Key Company Manufacturing Base & Headquarters Table 9. Global Microphysiological System Company, Product Type & Application Table 10. Global Microphysiological System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microphysiological System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Human Organ and Tissue Models Table 15. Significant Companies of Disease Models Table 16. Significant Companies of Non-Human Species Models Table 17. Global Microphysiological System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Microphysiological System Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Microphysiological System Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Microphysiological System Sales Value Share by Type (2021-2026) Table 21. Global Microphysiological System Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical & Biotechnology Companies Table 23. Significant Companies of Academic & Research Institutes Table 24. Significant Companies of Others Table 25. Global Microphysiological System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microphysiological System Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Microphysiological System Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Microphysiological System Sales Value Share by Application (2021-2026) Table 29. Global Microphysiological System Sales Value Share by Application (2027-2032) Table 30. Global Microphysiological System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Microphysiological System Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Microphysiological System Sales Value Share by Region (2021-2026) Table 33. Global Microphysiological System Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Microphysiological System Sales Value Share by Region (2027-2032) Table 35. Global Microphysiological System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Microphysiological System Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Microphysiological System Sales Value Market Share by Country (2021-2026) Table 38. Global Microphysiological System Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Microphysiological System Sales Value Market Share by Country (2027-2032) Table 40. Emulate Company Information Table 41. Emulate Business Overview Table 42. Emulate Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Emulate Microphysiological System Product Portfolio Table 44. Emulate Recent Development Table 45. Mimetas Company Information Table 46. Mimetas Business Overview Table 47. Mimetas Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Mimetas Microphysiological System Product Portfolio Table 49. Mimetas Recent Development Table 50. TissUse Company Information Table 51. TissUse Business Overview Table 52. TissUse Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. TissUse Microphysiological System Product Portfolio Table 54. TissUse Recent Development Table 55. InSphero Company Information Table 56. InSphero Business Overview Table 57. InSphero Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. InSphero Microphysiological System Product Portfolio Table 59. InSphero Recent Development Table 60. Hesperos Company Information Table 61. Hesperos Business Overview Table 62. Hesperos Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Hesperos Microphysiological System Product Portfolio Table 64. Hesperos Recent Development Table 65. CN Bio Company Information Table 66. CN Bio Business Overview Table 67. CN Bio Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. CN Bio Microphysiological System Product Portfolio Table 69. CN Bio Recent Development Table 70. TNO Company Information Table 71. TNO Business Overview Table 72. TNO Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. TNO Microphysiological System Product Portfolio Table 74. TNO Recent Development Table 75. 28bio Company Information Table 76. 28bio Business Overview Table 77. 28bio Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. 28bio Microphysiological System Product Portfolio Table 79. 28bio Recent Development Table 80. Beijing Daxiang Biotech Company Information Table 81. Beijing Daxiang Biotech Business Overview Table 82. Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Beijing Daxiang Biotech Microphysiological System Product Portfolio Table 84. Beijing Daxiang Biotech Recent Development Table 85. Newcells Biotech Company Information Table 86. Newcells Biotech Business Overview Table 87. Newcells Biotech Microphysiological System Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Newcells Biotech Microphysiological System Product Portfolio Table 89. Newcells Biotech Recent Development Table 90. Nortis (Quris-Al) Company Information Table 91. Nortis (Quris-Al) Business Overview Table 92. Nortis (Quris-Al) Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Nortis (Quris-Al) Microphysiological System Product Portfolio Table 94. Nortis (Quris-Al) Recent Development Table 95. Valo Health (TARA Biosystems) Company Information Table 96. Valo Health (TARA Biosystems) Business Overview Table 97. Valo Health (TARA Biosystems) Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Valo Health (TARA Biosystems) Microphysiological System Product Portfolio Table 99. Valo Health (TARA Biosystems) Recent Development Table 100. Altis Biosystems Company Information Table 101. Altis Biosystems Business Overview Table 102. Altis Biosystems Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Altis Biosystems Microphysiological System Product Portfolio Table 104. Altis Biosystems Recent Development Table 105. Draper Laboratory Company Information Table 106. Draper Laboratory Business Overview Table 107. Draper Laboratory Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Draper Laboratory Microphysiological System Product Portfolio Table 109. Draper Laboratory Recent Development Table 110. Netri Company Information Table 111. Netri Business Overview Table 112. Netri Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Netri Microphysiological System Product Portfolio Table 114. Netri Recent Development Table 115. Bi/ond Company Information Table 116. Bi/ond Business Overview Table 117. Bi/ond Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Bi/ond Microphysiological System Product Portfolio Table 119. Bi/ond Recent Development Table 120. ImmuONE Company Information Table 121. ImmuONE Business Overview Table 122. ImmuONE Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. ImmuONE Microphysiological System Product Portfolio Table 124. ImmuONE Recent Development Table 125. AlveoliX Company Information Table 126. AlveoliX Business Overview Table 127. AlveoliX Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. AlveoliX Microphysiological System Product Portfolio Table 129. AlveoliX Recent Development Table 130. Cherry Biotech Company Information Table 131. Cherry Biotech Business Overview Table 132. Cherry Biotech Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Cherry Biotech Microphysiological System Product Portfolio Table 134. Cherry Biotech Recent Development Table 135. Ananda Devices Company Information Table 136. Ananda Devices Business Overview Table 137. Ananda Devices Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Ananda Devices Microphysiological System Product Portfolio Table 139. Ananda Devices Recent Development Table 140. Obatala Sciences Company Information Table 141. Obatala Sciences Business Overview Table 142. Obatala Sciences Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Obatala Sciences Microphysiological System Product Portfolio Table 144. Obatala Sciences Recent Development Table 145. BiomimX Company Information Table 146. BiomimX Business Overview Table 147. BiomimX Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. BiomimX Microphysiological System Product Portfolio Table 149. BiomimX Recent Development Table 150. React4life Company Information Table 151. React4life Business Overview Table 152. React4life Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. React4life Microphysiological System Product Portfolio Table 154. React4life Recent Development Table 155. Aracari Bio Company Information Table 156. Aracari Bio Business Overview Table 157. Aracari Bio Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Aracari Bio Microphysiological System Product Portfolio Table 159. Aracari Bio Recent Development Table 160. StemPharm Company Information Table 161. StemPharm Business Overview Table 162. StemPharm Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. StemPharm Microphysiological System Product Portfolio Table 164. StemPharm Recent Development Table 165. SynVivo Company Information Table 166. SynVivo Business Overview Table 167. SynVivo Microphysiological System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. SynVivo Microphysiological System Product Portfolio Table 169. SynVivo Recent Development Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Microphysiological System Product Image Figure 2. Global Microphysiological System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microphysiological System Market Size (2021-2032) & (US$ Million) Figure 4. Global Microphysiological System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Human Organ and Tissue Models Image Figure 8. Disease Models Image Figure 9. Non-Human Species Models Image Figure 10. Global Microphysiological System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Microphysiological System Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Microphysiological System Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical & Biotechnology Companies Image Figure 14. Academic & Research Institutes Image Figure 15. Others Image Figure 16. Global Microphysiological System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microphysiological System Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Microphysiological System Sales Value Share by Application (2021-2032) Figure 19. Global Microphysiological System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Microphysiological System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Microphysiological System Sales Value (2021-2032) & (US$ Million) Figure 22. North America Microphysiological System Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Microphysiological System Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Microphysiological System Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Microphysiological System Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Microphysiological System Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Microphysiological System Sales Value (2021-2032) & (US$ Million) Figure 28. South America Microphysiological System Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Microphysiological System Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Microphysiological System Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Microphysiological System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Microphysiological System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Microphysiological System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Human Organ and Tissue Models
  • Disease Models
  • Non-Human Species Models
Applications
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
Companies covered
  • Emulate
  • Mimetas
  • TissUse
  • InSphero
  • Hesperos
  • CN Bio
  • TNO
  • 28bio
  • Beijing Daxiang Biotech
  • Newcells Biotech
  • Nortis (Quris-Al)
  • Valo Health (TARA Biosystems)
  • Altis Biosystems
  • Draper Laboratory
  • Netri
  • Bi/ond
  • ImmuONE
  • AlveoliX
  • Cherry Biotech
  • Ananda Devices
  • Obatala Sciences
  • BiomimX
  • React4life
  • Aracari Bio
  • StemPharm
  • SynVivo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microphysiological System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microphysiological System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microphysiological System Market Dynamics
  1. 2.1 Microphysiological System Industry Trends
  2. 2.2 Microphysiological System Industry Drivers
  3. 2.3 Microphysiological System Industry Opportunities and Challenges
  4. 2.4 Microphysiological System Industry Restraints
3 Microphysiological System Market by Company
  1. 3.1 Global Microphysiological System Company Revenue Ranking in 2025
  2. 3.2 Global Microphysiological System Revenue by Company (2021-2026)
  3. 3.3 Global Microphysiological System Company Ranking (2024-2026)
  4. 3.4 Global Microphysiological System Company Manufacturing Base and Headquarters
  5. 3.5 Global Microphysiological System Company Product Type and Application
  6. 3.6 Global Microphysiological System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microphysiological System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microphysiological System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microphysiological System Market by Type
  1. 4.1 Microphysiological System Type Introduction
  2. 4.1.1 Human Organ and Tissue Models
  3. 4.1.2 Disease Models
  4. 4.1.3 Non-Human Species Models
  5. 4.2 Global Microphysiological System Sales Value by Type
  6. 4.2.1 Global Microphysiological System Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Microphysiological System Sales Value by Type (2021-2032)
  8. 4.2.3 Global Microphysiological System Sales Value Share by Type (2021-2032)
5 Microphysiological System Market by Application
  1. 5.1 Microphysiological System Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Academic & Research Institutes
  4. 5.1.3 Others
  5. 5.2 Global Microphysiological System Sales Value by Application
  6. 5.2.1 Global Microphysiological System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microphysiological System Sales Value by Application (2021-2032)
  8. 5.2.3 Global Microphysiological System Sales Value Share by Application (2021-2032)
6 Microphysiological System Regional Value Analysis
  1. 6.1 Global Microphysiological System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microphysiological System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microphysiological System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microphysiological System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microphysiological System Sales Value (2021-2032)
  7. 6.3.2 North America Microphysiological System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microphysiological System Sales Value (2021-2032)
  10. 6.4.2 Europe Microphysiological System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microphysiological System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microphysiological System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microphysiological System Sales Value (2021-2032)
  16. 6.6.2 South America Microphysiological System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microphysiological System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microphysiological System Sales Value Share by Country, 2025 VS 2032
7 Microphysiological System Country-level Value Analysis
  1. 7.1 Global Microphysiological System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microphysiological System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microphysiological System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microphysiological System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microphysiological System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microphysiological System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microphysiological System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microphysiological System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microphysiological System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microphysiological System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microphysiological System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microphysiological System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microphysiological System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microphysiological System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microphysiological System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microphysiological System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microphysiological System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microphysiological System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microphysiological System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microphysiological System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microphysiological System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microphysiological System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microphysiological System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microphysiological System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microphysiological System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microphysiological System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microphysiological System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microphysiological System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microphysiological System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microphysiological System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microphysiological System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microphysiological System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microphysiological System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microphysiological System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microphysiological System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microphysiological System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microphysiological System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microphysiological System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microphysiological System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microphysiological System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microphysiological System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microphysiological System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microphysiological System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microphysiological System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microphysiological System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microphysiological System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microphysiological System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microphysiological System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microphysiological System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microphysiological System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microphysiological System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microphysiological System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microphysiological System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microphysiological System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microphysiological System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microphysiological System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microphysiological System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microphysiological System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microphysiological System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microphysiological System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microphysiological System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microphysiological System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microphysiological System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microphysiological System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microphysiological System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microphysiological System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microphysiological System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microphysiological System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microphysiological System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microphysiological System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microphysiological System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microphysiological System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microphysiological System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microphysiological System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microphysiological System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microphysiological System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microphysiological System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microphysiological System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microphysiological System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microphysiological System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microphysiological System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microphysiological System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microphysiological System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microphysiological System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microphysiological System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microphysiological System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microphysiological System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microphysiological System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Emulate
  2. 8.1.1 Emulate Company Information
  3. 8.1.2 Emulate Business Overview
  4. 8.1.3 Emulate Microphysiological System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Emulate Microphysiological System Product Portfolio
  6. 8.1.5 Emulate Recent Developments
  7. 8.2 Mimetas
  8. 8.2.1 Mimetas Company Information
  9. 8.2.2 Mimetas Business Overview
  10. 8.2.3 Mimetas Microphysiological System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mimetas Microphysiological System Product Portfolio
  12. 8.2.5 Mimetas Recent Developments
  13. 8.3 TissUse
  14. 8.3.1 TissUse Company Information
  15. 8.3.2 TissUse Business Overview
  16. 8.3.3 TissUse Microphysiological System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TissUse Microphysiological System Product Portfolio
  18. 8.3.5 TissUse Recent Developments
  19. 8.4 InSphero
  20. 8.4.1 InSphero Company Information
  21. 8.4.2 InSphero Business Overview
  22. 8.4.3 InSphero Microphysiological System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 InSphero Microphysiological System Product Portfolio
  24. 8.4.5 InSphero Recent Developments
  25. 8.5 Hesperos
  26. 8.5.1 Hesperos Company Information
  27. 8.5.2 Hesperos Business Overview
  28. 8.5.3 Hesperos Microphysiological System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hesperos Microphysiological System Product Portfolio
  30. 8.5.5 Hesperos Recent Developments
  31. 8.6 CN Bio
  32. 8.6.1 CN Bio Company Information
  33. 8.6.2 CN Bio Business Overview
  34. 8.6.3 CN Bio Microphysiological System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CN Bio Microphysiological System Product Portfolio
  36. 8.6.5 CN Bio Recent Developments
  37. 8.7 TNO
  38. 8.7.1 TNO Company Information
  39. 8.7.2 TNO Business Overview
  40. 8.7.3 TNO Microphysiological System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 TNO Microphysiological System Product Portfolio
  42. 8.7.5 TNO Recent Developments
  43. 8.8 28bio
  44. 8.8.1 28bio Company Information
  45. 8.8.2 28bio Business Overview
  46. 8.8.3 28bio Microphysiological System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 28bio Microphysiological System Product Portfolio
  48. 8.8.5 28bio Recent Developments
  49. 8.9 Beijing Daxiang Biotech
  50. 8.9.1 Beijing Daxiang Biotech Company Information
  51. 8.9.2 Beijing Daxiang Biotech Business Overview
  52. 8.9.3 Beijing Daxiang Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Daxiang Biotech Microphysiological System Product Portfolio
  54. 8.9.5 Beijing Daxiang Biotech Recent Developments
  55. 8.10 Newcells Biotech
  56. 8.10.1 Newcells Biotech Company Information
  57. 8.10.2 Newcells Biotech Business Overview
  58. 8.10.3 Newcells Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Newcells Biotech Microphysiological System Product Portfolio
  60. 8.10.5 Newcells Biotech Recent Developments
  61. 8.11 Nortis (Quris-Al)
  62. 8.11.1 Nortis (Quris-Al) Company Information
  63. 8.11.2 Nortis (Quris-Al) Business Overview
  64. 8.11.3 Nortis (Quris-Al) Microphysiological System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nortis (Quris-Al) Microphysiological System Product Portfolio
  66. 8.11.5 Nortis (Quris-Al) Recent Developments
  67. 8.12 Valo Health (TARA Biosystems)
  68. 8.12.1 Valo Health (TARA Biosystems) Company Information
  69. 8.12.2 Valo Health (TARA Biosystems) Business Overview
  70. 8.12.3 Valo Health (TARA Biosystems) Microphysiological System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Valo Health (TARA Biosystems) Microphysiological System Product Portfolio
  72. 8.12.5 Valo Health (TARA Biosystems) Recent Developments
  73. 8.13 Altis Biosystems
  74. 8.13.1 Altis Biosystems Company Information
  75. 8.13.2 Altis Biosystems Business Overview
  76. 8.13.3 Altis Biosystems Microphysiological System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Altis Biosystems Microphysiological System Product Portfolio
  78. 8.13.5 Altis Biosystems Recent Developments
  79. 8.14 Draper Laboratory
  80. 8.14.1 Draper Laboratory Company Information
  81. 8.14.2 Draper Laboratory Business Overview
  82. 8.14.3 Draper Laboratory Microphysiological System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Draper Laboratory Microphysiological System Product Portfolio
  84. 8.14.5 Draper Laboratory Recent Developments
  85. 8.15 Netri
  86. 8.15.1 Netri Company Information
  87. 8.15.2 Netri Business Overview
  88. 8.15.3 Netri Microphysiological System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Netri Microphysiological System Product Portfolio
  90. 8.15.5 Netri Recent Developments
  91. 8.16 Bi/ond
  92. 8.16.1 Bi/ond Company Information
  93. 8.16.2 Bi/ond Business Overview
  94. 8.16.3 Bi/ond Microphysiological System Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bi/ond Microphysiological System Product Portfolio
  96. 8.16.5 Bi/ond Recent Developments
  97. 8.17 ImmuONE
  98. 8.17.1 ImmuONE Company Information
  99. 8.17.2 ImmuONE Business Overview
  100. 8.17.3 ImmuONE Microphysiological System Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ImmuONE Microphysiological System Product Portfolio
  102. 8.17.5 ImmuONE Recent Developments
  103. 8.18 AlveoliX
  104. 8.18.1 AlveoliX Company Information
  105. 8.18.2 AlveoliX Business Overview
  106. 8.18.3 AlveoliX Microphysiological System Revenue and Gross Margin (2021-2026)
  107. 8.18.4 AlveoliX Microphysiological System Product Portfolio
  108. 8.18.5 AlveoliX Recent Developments
  109. 8.19 Cherry Biotech
  110. 8.19.1 Cherry Biotech Company Information
  111. 8.19.2 Cherry Biotech Business Overview
  112. 8.19.3 Cherry Biotech Microphysiological System Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Cherry Biotech Microphysiological System Product Portfolio
  114. 8.19.5 Cherry Biotech Recent Developments
  115. 8.20 Ananda Devices
  116. 8.20.1 Ananda Devices Company Information
  117. 8.20.2 Ananda Devices Business Overview
  118. 8.20.3 Ananda Devices Microphysiological System Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ananda Devices Microphysiological System Product Portfolio
  120. 8.20.5 Ananda Devices Recent Developments
  121. 8.21 Obatala Sciences
  122. 8.21.1 Obatala Sciences Company Information
  123. 8.21.2 Obatala Sciences Business Overview
  124. 8.21.3 Obatala Sciences Microphysiological System Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Obatala Sciences Microphysiological System Product Portfolio
  126. 8.21.5 Obatala Sciences Recent Developments
  127. 8.22 BiomimX
  128. 8.22.1 BiomimX Company Information
  129. 8.22.2 BiomimX Business Overview
  130. 8.22.3 BiomimX Microphysiological System Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BiomimX Microphysiological System Product Portfolio
  132. 8.22.5 BiomimX Recent Developments
  133. 8.23 React4life
  134. 8.23.1 React4life Company Information
  135. 8.23.2 React4life Business Overview
  136. 8.23.3 React4life Microphysiological System Revenue and Gross Margin (2021-2026)
  137. 8.23.4 React4life Microphysiological System Product Portfolio
  138. 8.23.5 React4life Recent Developments
  139. 8.24 Aracari Bio
  140. 8.24.1 Aracari Bio Company Information
  141. 8.24.2 Aracari Bio Business Overview
  142. 8.24.3 Aracari Bio Microphysiological System Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Aracari Bio Microphysiological System Product Portfolio
  144. 8.24.5 Aracari Bio Recent Developments
  145. 8.25 StemPharm
  146. 8.25.1 StemPharm Company Information
  147. 8.25.2 StemPharm Business Overview
  148. 8.25.3 StemPharm Microphysiological System Revenue and Gross Margin (2021-2026)
  149. 8.25.4 StemPharm Microphysiological System Product Portfolio
  150. 8.25.5 StemPharm Recent Developments
  151. 8.26 SynVivo
  152. 8.26.1 SynVivo Company Information
  153. 8.26.2 SynVivo Business Overview
  154. 8.26.3 SynVivo Microphysiological System Revenue and Gross Margin (2021-2026)
  155. 8.26.4 SynVivo Microphysiological System Product Portfolio
  156. 8.26.5 SynVivo Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst